array CGH
The company is positioning the blood-based test as an alternative to invasive chorionic villus sampling, the current standard in Denmark.
The British molecular diagnostics company received a CE-IVD mark for the assay, called BCA-1, in June, and launched the test in October.
Denmark-based Arcedi would like to commercialize its technology through a major diagnostic company.
NanoVelcro Microchips Can Capture Fetal Cells from Maternal Blood for Prenatal Genetic Testing
Premium
A UCLA group and spinout FetoLumina Technologies are working on a clinical assay for noninvasive prenatal diagnostics.
Sysmex to Acquire Oxford Gene Technology
The acquisition allows Sysmex to enter the cytogenetics market and strengthens its technology base in molecular genetics, while expanding its life science business.